Economic Evaluations of Everolimus Versus Other Hormonal Therapies in the Treatment of HR+/HER2− Advanced Breast Cancer From a US Payer Perspective
2015 · Clinical Breast Cancer · 27 citations
https://doi.org/10.1016/j.clbc.2015.04.001
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
312
Citations
7
h-index
7
i10-index
Gourab De is an academic researcher from International Management Institute. The author has contributed to research in topics: Genetic Associations and Epidemiology & Health Systems, Economic Evaluations, Quality of Life & Behavioral Health and Interventions. The author has an h-index of 7, co-authored 17 publications.
ORCID: 0000-0001-6768-8135https://doi.org/10.1016/j.clbc.2015.04.001
https://doi.org/10.3111/13696998.2012.749788
Click to start Chat